| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| 50mg |
|
||
| 100mg |
|
||
| 250mg | |||
| Other Sizes |
| ln Vivo |
Afoxolaner's minimum effective dose of 2.5 mg/kg, when taken as a single oral therapy, was found to be 98% to 100% effective on day 30 and to be effective in eliminating pre-existing scapularis tick infections and weekly reinfections up until day 23 [1].
|
|---|---|
| References |
[1]. Mitchell EB, et al. Efficacy of afoxolaner against Ixodes scapularis ticks in dogs.Vet Parasitol. 2014 Apr 2;201(3-4):223-5.
[2]. Beugnet F, et al. Afoxolaner against fleas: immediate efficacy and resultant mortality after short exposure on dogs.Parasite. 2014;21:42. |
| Additional Infomation |
See also: Aflonana; Moxicillin; Praziquantel (ingredient).
Drug Indications Treatment of flea (Ctenophora catinatum and Ctenophora canis) infestations. This product can be used as part of a treatment regimen for flea allergic dermatitis (FAD). Treatment of tick (Reticulated tick, Castor tick, Red-brown tick) infestations. Treatment of canine demodicosis (caused by Demodex canis). Treatment of scabies (caused by Sarcoptes canis). Treatment of canine flea infestations (Ctenophora catinatum and Ctenophora canis) for at least 5 weeks. This product can be used as part of a treatment regimen for flea allergic dermatitis (FAD). For the treatment of canine tick infestations (including Reticulated tick, Castor tick, Hexagonal tick, and Red-brown tick). A single treatment can kill ticks for up to one month. Fleas and ticks must attach to a host and begin feeding to reach the active ingredient. It is used to treat canine demodicosis (caused by Demodex folliculorum) and scabies (caused by Sarcoptes aeruginosa). |
| Molecular Formula |
C26H17CLF9N3O3
|
|---|---|
| Molecular Weight |
625.870116949081
|
| Exact Mass |
625.081
|
| CAS # |
1093861-60-9
|
| Related CAS # |
1093861-60-9 (Afoxolaner);1096103-99-9 (Esafoxolaner);
|
| PubChem CID |
25154249
|
| Appearance |
White to off-white solid powder
|
| LogP |
6.719
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
13
|
| Rotatable Bond Count |
6
|
| Heavy Atom Count |
42
|
| Complexity |
1040
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
ClC1C=C(C(F)(F)F)C=C(C=1)C1(C(F)(F)F)CC(C2=CC=C(C(NCC(NCC(F)(F)F)=O)=O)C3C=CC=CC2=3)=NO1
|
| InChi Key |
OXDDDHGGRFRLEE-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C26H17ClF9N3O3/c27-15-8-13(7-14(9-15)25(31,32)33)23(26(34,35)36)10-20(39-42-23)18-5-6-19(17-4-2-1-3-16(17)18)22(41)37-11-21(40)38-12-24(28,29)30/h1-9H,10-12H2,(H,37,41)(H,38,40)
|
| Chemical Name |
4-[5-[3-chloro-5-(trifluoromethyl)phenyl]-5-(trifluoromethyl)-4H-1,2-oxazol-3-yl]-N-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]naphthalene-1-carboxamide
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO : ≥ 250 mg/mL (~399.44 mM)
|
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.25 mg/mL (3.59 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 22.5 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.25 mg/mL (3.59 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 22.5 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.5978 mL | 7.9889 mL | 15.9778 mL | |
| 5 mM | 0.3196 mL | 1.5978 mL | 3.1956 mL | |
| 10 mM | 0.1598 mL | 0.7989 mL | 1.5978 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
